Beijing, China

Xuemin Zhang

USPTO Granted Patents = 4 

Average Co-Inventor Count = 5.2

ph-index = 1


Company Filing History:


Years Active: 2015-2023

Loading Chart...
4 patents (USPTO):

Title: Xuemin Zhang: Innovator in Hydroquinone Compounds

Introduction

Xuemin Zhang is a prominent inventor based in Beijing, China. He has made significant contributions to the field of pharmacology, particularly in the development of hydroquinone compounds. With a total of 4 patents, his work focuses on innovative methods and applications in anti-tumor and immunomodulation therapies.

Latest Patents

Xuemin Zhang's latest patents include groundbreaking research on hydroquinone compounds and their preparation methods. One of his notable inventions involves hydroquinone compounds that are utilized in anti-tumor or immunomodulation therapy. These compounds are designed to slowly release 2-tert-butyl-4-methoxyphenol in vivo, maintaining a stable plasma concentration over time. Additionally, he has developed a stable crystal form of 2-tert-butyl-4-methoxyphenol, which is crucial for preparing effective antitumor and immunomodulator drugs.

Career Highlights

Throughout his career, Xuemin Zhang has worked at esteemed institutions such as the Biomedical Analysis Center and the Institute of Pharmacology and Toxicology, both part of the Academy of Military Medical Sciences. His research has significantly advanced the understanding and application of hydroquinone compounds in medical therapies.

Collaborations

Xuemin Zhang has collaborated with notable colleagues, including Tao Zhou and Xinhua He. Their joint efforts have contributed to the successful development of innovative therapeutic solutions.

Conclusion

Xuemin Zhang's contributions to the field of pharmacology through his patents and research have established him as a key figure in the development of hydroquinone compounds. His work continues to influence the landscape of anti-tumor and immunomodulation therapies.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…